{"id":"W2564858174","doi":"10.1200/jco.2011.29.4_suppl.88","title":"A global, multicenter phase II trial of lapatinib plus capecitabine in gastric cancer.","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Lapatinib; Capecitabine; Medicine; Internal medicine; Cancer; Gastroenterology; Oncology; Progressive disease; Tyrosine-kinase inhibitor; Phases of clinical research; Response Evaluation Criteria in Solid Tumors; Clinical endpoint; Chemotherapy; Clinical trial; Trastuzumab; Breast cancer; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001838806,0.0001252033,0.00162325,0.0001881465,0.00001605891,0.000002171987,0.0001911341,0.0001909987,0.0007741764],"category_scores_gemma":[0.001964267,0.00008971705,0.0004641231,0.0003486429,0.0001353755,0.00008881586,0.00008852887,0.0004549567,0.000003654119],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002911333,"about_ca_system_score_gemma":0.001128612,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003361029,"about_ca_topic_score_gemma":0.0004516897,"domain_scores_codex":[0.9962917,0.0001935117,0.002789622,0.0001520047,0.0003345437,0.0002386383],"domain_scores_gemma":[0.9969935,0.0003985861,0.001939522,0.0001648666,0.0002659939,0.0002375354],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3883598,0.0117925,0.2158649,0.00005873387,0.0004404582,0.0007084833,0.0002577674,0.0000091867,0.00001528597,0.00007000069,0.009003287,0.3734196],"study_design_scores_gemma":[0.5398208,0.09407476,0.3336862,0.00015529,0.0007473797,0.00005162457,0.0002302044,0.0001639148,0.00001318993,0.00009976583,0.03085944,0.00009739468],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9882516,0.0003039491,0.0001173142,0.002273587,0.002637463,0.000415506,0.000007080781,0.000005297886,0.005988198],"genre_scores_gemma":[0.9933602,0.0008851563,0.003287084,0.001050801,0.001090731,0.000007944195,0.00000128146,0.000008300804,0.0003085476],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3733222,"threshold_uncertainty_score":0.8476689,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1925745319882942,"score_gpt":0.4948396367741353,"score_spread":0.3022651047858411,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}